Latest news with #NovaIVF
&w=3840&q=100)
Business Standard
22-06-2025
- Health
- Business Standard
IVF players on expansion mode in smaller towns as fertility rates go down
Major in-vitro fertilisation (IVF) chains are expanding into untapped Tier 2 and 3 cities, driven by improved healthcare infrastructure, growing acceptance of fertility treatments, and rising disposable incomes in smaller urban centres. Birla Fertility and IVF, which currently operates around 30 centres in Tier 2 and 3 cities, plans to open at least 15 to 16 more centres in FY26, two-thirds of which will be in smaller towns. Nova IVF, which derives 40 per cent of its revenue from such cities, is exploring expansion in 15 locations including Haldwani, Jamnagar and Meerut. Indira IVF, the country's largest infertility chain, has also announced plans to enter over 25 Tier 3 cities by FY27. Explaining the rationale, Shobhit Agarwal, Chief Executive Officer (CEO) of Nova IVF Fertility, said, 'With one in six couples experiencing infertility in India, there is a need for fertility chains to expand to cater to couples battling infertility.' A recent United Nations Population Fund (UNFPA) report highlighted that India's total fertility rate (TFR) has fallen to 1.9 births per woman — below the replacement level of 2.1. The report echoes findings from the National Family Health Survey (NFHS)-5, which pegged India's TFR at 2.0 births per woman for 2019–21. The NFHS-5 also found the fertility rate had declined more significantly in rural areas, where it stood at 2.1 — down from 3.7 in NFHS-1 (1992–93). In urban areas, it fell to 1.6 from 2.7 in the same period. While infertility is not the sole factor behind the falling TFR, experts suggest infertility cases are expected to rise beyond Tier 1 cities, fuelled by stress-related lifestyle diseases and climate change. Industry insiders say IVF players are already witnessing increased demand for infertility treatment from Tier 2 and 3 cities. Abhishek Aggrawal, CEO of Birla Fertility and IVF, told Business Standard that more than 50 per cent of the company's annual IVF cycles are conducted in cities such as Siliguri, Varanasi and Prayagraj. 'While there is a rising segment in metros, with IVF chains receiving queries from women for procedures like egg freezing to delay parenthood, Tier 2 cities are providing an opportunity to tap less penetrated, high-potential markets,' he said. Agarwal added that many couples from Tier 2 regions find it difficult to travel to larger cities for fertility treatment, as the cost of travel, accommodation and lost wages makes the process financially burdensome. 'With expansion, we are bringing standardised fertility treatment to their home towns, with the best clinical acumen and embryologists,' he said. This model, he added, is affordable and avoids additional hassle. India currently performs around 200,000 to 250,000 IVF cycles annually, and the market is projected to grow to 400,000 cycles by 2030, with smaller cities expected to account for a substantial share of this growth. Aggrawal noted that to meet this growing demand, IVF chains are also focusing on building awareness to ensure fertility care is both accessible and better understood by those in need.
Business Wire
13-05-2025
- Health
- Business Wire
Nova IVF, an Ivy Fertility Clinic, Hires Dr. Anna Sokalska
SAN DIEGO--(BUSINESS WIRE)--Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Anna Sokalska, MD, PhD to its collaborative team of physicians at Nova IVF in Mountain View, California. Dr. Sokalska is double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She will begin seeing patients at Nova IVF on June 30, 2025. Dr. Sokalska brings an extraordinary combination of scientific rigor, international experience, and heartfelt dedication. Dr. Sokalska received her medical degree from Poznan University of Medical Sciences in Poland. She completed residencies in obstetrics and gynecology at Poznan and University of Pennsylvania, a research fellowship at Lund University in Malmö, Sweden, and a postdoctoral fellowship at UC Davis. She then completed her fellowship in Reproductive Endocrinology and Infertility at the University of Pennsylvania. She comes to Nova IVF from Stanford School of Medicine, where she serves as clinical assistant professor and director of the Fertility Preservation Program. 'I am honored to join the team at Nova IVF, where clinical excellence and patient-centered care are top priorities,' said Dr. Sokalska. 'I look forward to working alongside their excellent team and supporting patients with compassion, curiosity, and evidence-based care.' Nova IVF has been building families in the South Bay Area for over 35 years and has IVF success rates up to 50% higher than the national average. Dr. Sokalska joins Richard Schmidt, MD and Meera Shah, MD on the physician team, enabling Ivy Fertility to serve a growing number of patients throughout Silicon Valley and beyond. 'Dr. Sokalska brings an extraordinary combination of scientific rigor, international experience, and heartfelt dedication to fertility care,' said Dr. Schmidt, Medical Director at Nova IVF. 'We're excited for our patients to benefit from her expertise and warm, individualized approach.' About Ivy Fertility Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents.
Yahoo
13-05-2025
- Health
- Yahoo
Nova IVF, an Ivy Fertility Clinic, Hires Dr. Anna Sokalska
SAN DIEGO, May 13, 2025--(BUSINESS WIRE)--Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Anna Sokalska, MD, PhD to its collaborative team of physicians at Nova IVF in Mountain View, California. Dr. Sokalska is double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She will begin seeing patients at Nova IVF on June 30, 2025. Dr. Sokalska received her medical degree from Poznan University of Medical Sciences in Poland. She completed residencies in obstetrics and gynecology at Poznan and University of Pennsylvania, a research fellowship at Lund University in Malmö, Sweden, and a postdoctoral fellowship at UC Davis. She then completed her fellowship in Reproductive Endocrinology and Infertility at the University of Pennsylvania. She comes to Nova IVF from Stanford School of Medicine, where she serves as clinical assistant professor and director of the Fertility Preservation Program. "I am honored to join the team at Nova IVF, where clinical excellence and patient-centered care are top priorities," said Dr. Sokalska. "I look forward to working alongside their excellent team and supporting patients with compassion, curiosity, and evidence-based care." Nova IVF has been building families in the South Bay Area for over 35 years and has IVF success rates up to 50% higher than the national average. Dr. Sokalska joins Richard Schmidt, MD and Meera Shah, MD on the physician team, enabling Ivy Fertility to serve a growing number of patients throughout Silicon Valley and beyond. "Dr. Sokalska brings an extraordinary combination of scientific rigor, international experience, and heartfelt dedication to fertility care," said Dr. Schmidt, Medical Director at Nova IVF. "We're excited for our patients to benefit from her expertise and warm, individualized approach." About Ivy Fertility Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents. View source version on Contacts Constance Rapsonconstance@
